Ligand Pharmaceuticals Ratios and Metrics

Market cap in millions USD. Fiscal year is July - June.

Millions USD. Fiscal year is Jul - Jun.

Fiscal Year	Current	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Aug '25 Aug 1, 2025	Jun '23 Jun 30, 2023	Jun '22 Jun 30, 2022	Jun '21 Jun 30, 2021	Jun '20 Jun 30, 2020
Market Capitalization	0	296	218	214	-
Market Cap Growth	-79.60%	35.91%	1.81%	-	-
Enterprise Value	58	329	344	234	-
Last Close Price	0.00	5.22	10.11	9.93	-
PS Ratio	0.00	11.34	7.18	7.16	-
PB Ratio	0.00	-6.55	-1.78	-3.06	-
EV/Sales Ratio	3.06	12.61	11.33	7.81	-
Debt / Equity Ratio	-1.07	-1.23	-1.03	-1.42	-1.12
Asset Turnover	0.55	0.68	0.60	0.49	-
Inventory Turnover	55.89	32.64	12.69	5.45	-
Quick Ratio	0.08	0.28	0.03	0.69	0.18
Current Ratio	0.11	0.51	0.10	0.98	0.67
Return on Assets (ROA)	-104.04%	-83.05%	-38.22%	-16.96%	-
Return on Capital (ROIC)	-169.85%	-455.95%	-116.07%	-64.68%	-
Earnings Yield	-94533.51%	-11.64%	-25.83%	-23.26%	-
FCF Yield	-50293.91%	-15.12%	-21.82%	-11.11%	-
Buyback Yield / Dilution	-61.71%	-70.52%	-437.42%	-1.08%	-

Source: S&P Global Market Intelligence. Standard template. Financial Sources.